Expand raw payload
{
"awards": [
{
"id": "075277-2025-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-3470",
"name": "Roche Products Ltd"
},
{
"id": "GB-FTS-166986",
"name": "Pfizer"
},
{
"id": "GB-FTS-104515",
"name": "Amgen Ltd"
}
]
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 3
},
{
"id": "2",
"measure": "smeBids",
"relatedLot": "1",
"value": 0
},
{
"id": "3",
"measure": "foreignBidsFromEU",
"relatedLot": "1",
"value": 1
},
{
"id": "4",
"measure": "foreignBidsFromNonEU",
"relatedLot": "1",
"value": 2
},
{
"id": "5",
"measure": "electronicBids",
"relatedLot": "1",
"value": 3
}
]
},
"buyer": {
"id": "GB-FTS-115937",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"contracts": [
{
"awardID": "075277-2025-1",
"dateSigned": "2025-10-28T00:00:00Z",
"id": "075277-2025-1",
"status": "active",
"value": {
"amount": 8493876,
"currency": "GBP"
}
}
],
"date": "2025-11-19T14:34:58Z",
"description": "The estimated value(s) referred to in Section II.1.7 and V.2.4 cover(s) the thirty-six (36) month contract duration and the twelve (12) month extension period of the framework agreement.\n(SC Ref:816001)",
"id": "075277-2025",
"initiationType": "tender",
"language": "en",
"links": [
{
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000801515",
"rel": "canonical"
}
],
"ocid": "ocds-h6vhtk-056a43",
"parties": [
{
"address": {
"countryName": "United Kingdom",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"region": "UKM",
"streetAddress": "1 South Gyle Crescent"
},
"contactPoint": {
"email": "michelle.semple3@nhs.scot",
"telephone": "+44 1312756000"
},
"details": {
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
"classifications": [
{
"description": "Body governed by public law",
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE"
},
{
"description": "Health",
"id": "07",
"scheme": "COFOG"
}
],
"url": "http://www.nss.nhs.scot/browse/procurement-and-logistics"
},
"id": "GB-FTS-115937",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
"roles": [
"buyer",
"centralPurchasingBody"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Welwyn Garden City",
"postalCode": "AL7 1TW",
"region": "UK",
"streetAddress": "6 Falcon Way, Shire Park"
},
"contactPoint": {
"telephone": "+44 01707366171"
},
"details": {
"scale": "large"
},
"id": "GB-FTS-3470",
"identifier": {
"legalName": "Roche Products Ltd"
},
"name": "Roche Products Ltd",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Tadworth",
"postalCode": "KT20 7NS",
"region": "UK",
"streetAddress": "Pfizer Ltd, Walton Oaks, Dorking Road"
},
"contactPoint": {
"telephone": "+44 07341097250"
},
"details": {
"scale": "large"
},
"id": "GB-FTS-166986",
"identifier": {
"legalName": "Pfizer"
},
"name": "Pfizer",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Cambridge",
"postalCode": "CB4 0WD",
"region": "UK",
"streetAddress": "240 Cambridge Science Park, Milton Road"
},
"contactPoint": {
"faxNumber": "+44 01223228211",
"telephone": "+44 01223436406"
},
"details": {
"scale": "large"
},
"id": "GB-FTS-104515",
"identifier": {
"legalName": "Amgen Ltd"
},
"name": "Amgen Ltd",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"streetAddress": "27 Chambers Street"
},
"contactPoint": {
"telephone": "+44 1312252525"
},
"details": {
"url": "https://scotcourts.gov.uk/the-courts/sheriff-court/about-sheriff-courts"
},
"id": "GB-FTS-324",
"identifier": {
"legalName": "Sheriff Court House"
},
"name": "Sheriff Court House",
"roles": [
"reviewBody"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"classification": {
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
},
"coveredBy": [
"GPA"
],
"description": "Supply of Erythropoietin Stimulating Agents to NHS Scotland.",
"id": "ocds-h6vhtk-056a43",
"items": [
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"id": "1",
"relatedLot": "1"
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lots": [
{
"awardCriteria": {
"criteria": [
{
"description": "5",
"name": "Supply Chain",
"type": "quality"
},
{
"description": "95",
"type": "price"
}
]
},
"description": "Supply of Erythropoietin Stimulating Agents to NHS Scotland. The Authority intends to award this framework as a single supplier framework per line. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents. Include further framework-specific content if appropriate.",
"hasOptions": false,
"id": "1",
"status": "cancelled"
}
],
"mainProcurementCategory": "goods",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"reviewDetails": "The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a \u2018standstill period\u2019 of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"status": "complete",
"techniques": {
"hasFrameworkAgreement": true
},
"title": "NP40725 Erythropoietin Stimulating Agents"
}
}